Vectibix IV infusion 400mg, manufactured by Takeda Pharmaceutical, contains Panitumumab (genetical recombination). With YJ code 4291417A2027 and standard 400mg 20mL 1 bottle, it is a monoclonal antibody used for the treatment of certain types of metastatic colorectal cancer.
Vectibix IV infusion 400mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →